AtriCure, Inc. — Director's Dealing 2017

Mar 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2017-03-17

Reporting Person: LUX ANDREW L (SVP, Ops & Quality)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-17	Common Stock	M	20000	$6.27	Acquired	85589	Direct
2017-03-17	Common Stock	S	20000	$18.85	Disposed	65589	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-17	Stock Option (right to buy)	$6.27	M	20000	Disposed	2022-10-25	Common Stock (20000)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $18.64 to $18.99 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: These options were granted on October 25, 2012 and are exercisable as to 25% of the shares upon the one-year anniversary of the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.